Company: STAA
Filing Date: 2025-02-21
Form Type: 10-K
Source: 0000950170-25-024813
Chunk: 202

Company: STAAR SURGICAL CO
Filing Date: 2025-02-21
Form: 10-K
Item: Item 8
Chunk 202
---
947

    Accumulated other comprehensive income (loss)

    (7,031
    )

    (4,113
    )

    Accumulated deficit

    (67,576
    )

    (47,368
    )

    Total stockholders’ equity

    397,335

    385,954

    Total liabilities and stockholders’ equity
     
    $
    509,524

    $
    488,692

The accompanying notes are an integral part of these consolidated financial statements.

F-4

STAAR SURGICAL COMPANY AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

Years Ended December 27, 2024, December 29, 2023 and December 30, 2022

(In thousands, except per share amounts)

    2024

    2023

    2022

    Net sales
     
    $
    313,901

    $
    322,415

    $
    284,391

    Cost of sales

    74,319

    69,764

    61,008

    Gross profit

    239,582

    252,651

    223,383

    Selling, general and administrative expenses:

    General and administrative

    89,898

    72,319

    54,742

    Selling and marketing

    108,322

    107,834

    88,856

    Research and development

    53,973

    44,401

    35,983

    Total selling, general and administrative expenses

    252,193

    224,554

    179,581

    Operating income (loss)

    (12,611
    )

    28,097

    43,802

    Other income, net:

    Interest income, net

    5,911

    6,986

    2,448

    Loss on foreign currency transactions

    (3,675
    )

    (1,909
    )

    (1,707
    )

    Royalty income

    508

    74

    804

    Other income, net

    815

    448

    205

    Total other income, net

    3,559

    5,599

    1,750

    Income (loss